Scientists look to outliers in quest for cures

09/19/2013 | Reuters

Advances in genome sequencing technology are allowing researchers to study why some patients respond well to treatments that fail in others with the same disease. The research could lead to new uses for existing and abandoned compounds, researchers say. Projects are planned or underway at the National Cancer Institute, Memorial Sloan-Kettering Cancer Center, MD Anderson Cancer Center and Dana-Farber Cancer Institute, among others.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Operating Officer
Health Plan of San Joaquin
French Camp , CA
Chief Medical Officer, Texas Children's Health Plan
Cejka Executive Search for Texas Children's Health Plan
Houston, TX
Chief Information Officer
Meridian Health Plan
Detroit, MI
Actuary
NTA Life
Addison, TX
Vice President - Government Products
Health Alliance Plan
Detroit, MI